Mulmit

Alkermes plc.Alkermes plc.

ALKS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,475,899,000253,956,000241,700,0001.43
2024-12-311,557,632,000420,636,000367,100,0002.17
2023-12-311,663,405,000414,122,000355,800,0002.1
2022-12-311,111,795,000-6,089,000-158,300,000-0.97
2021-12-311,173,751,00097,746,000-48,200,000-0.29

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-03Gaffin David JosephEVP, CLO, Alkermes, Inc.2,034
2026-09-01Hopkinson Craig C.EVP R&D, Chief Medical Officer5,000
2026-09-01Hopkinson Craig C.EVP R&D, Chief Medical Officer9,000
2026-09-01Hopkinson Craig C.EVP R&D, Chief Medical Officer5,000
2026-08-17Nichols Christian ToddSVP, Chief Commercial Officer6,912
2026-08-17Nichols Christian ToddSVP, Chief Commercial Officer664
2026-08-05Jackson Blair CurtisPresident & CEO, Alkermes plc93,229
2026-08-05Jackson Blair CurtisPresident & CEO, Alkermes plc124,305
2026-08-03snyderman nancy lynn MD27,948
2026-08-03snyderman nancy lynn MD16,524
2026-08-03snyderman nancy lynn MD44,472
2026-08-03snyderman nancy lynn MD27,948

8-K events

FiledItems
2026-08-12Entry into a material agreement · Financial statements and exhibits
2026-08-03Officer or director change
2026-07-28Results of operations · Financial statements and exhibits
2026-07-08Termination of a material agreement
2026-06-15Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-20Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-12Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits

Congressional trades (PTR)

MemberFiled
Hon. Gilbert Cisneros2026-09-04
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.